Pfizer's Bold Gambit: Unlocking the Future of Obesity Treatment with Metsera and Oral GLP-1s
Pfizer's Bold Leap: Eyeing Metsara in Blockbuster Acquisition Bid
Metsera: The New Power Player Set to Disrupt the $100 Billion GLP-1 Market